Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
02/2003
02/19/2003EP1087777B1 Therapeutic dinucleotide and derivatives
02/18/2003US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis
02/13/2003WO2003012051A2 Inhibitor of dna methylation
02/13/2003WO2003011886A1 Method for producing mixed crystal of disodium 5'-guanylate and disodium 5'-inosinate
02/13/2003WO2003011885A1 Non-natural carbon-linked nucleotides and dinucleotides
02/13/2003WO2003011884A1 Process for the preparation of ribavirin
02/13/2003WO2003011883A2 Process for the preparation of l-ribavirin
02/13/2003WO2003011877A2 Process for preparing purine nucleosides
02/13/2003WO2003011221A2 PREPARATION AND USE OF α-KETO PHOSPHONATES
02/13/2003WO2002060454B1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
02/13/2003WO2002040701A3 Energy transfer labels with mechanically linked fluorophores
02/13/2003US20030032797 Process for the preparation of cytidine derivatives
02/13/2003US20030032796 New stable salts of S-adenosyl-L-methionine (SAMe) and the process for their preparation
02/13/2003US20030032794 Method for preparation of LNA phosphoramidites
02/13/2003US20030032785 Detection of ligand and ligand sequences in sample; obtain nucleotide sequence samples, partitioning sample, incubate with primers, propagate and amplify sequences
02/13/2003US20030032030 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging
02/13/2003CA2454147A1 Inhibitor of dna methylation
02/13/2003CA2449561A1 Process for preparing purine nucleosides
02/12/2003EP1283211A2 L-Nucleosides for the treatment of hepatitis B-virus and Epstein-barr virus
02/12/2003EP1282632A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
02/12/2003EP1252173A4 Purification of oligonucleotides
02/12/2003CN1396172A Process for extracting compound cordycepin and its Chinese medicine
02/11/2003US6518418 Which are phosphite linked; protected nucleoside monophosphite-glycoside using a phosphoramiditing agent; can use to produce nucleoside-monophosphate-glycosides
02/11/2003US6518254 Ribonucleoside-TRIBOSE
02/11/2003US6518253 Treatment of viral infections using the L-isomer of ribavirin
02/11/2003CA2092305C Compounds having antihypertensive and anti-ischemic properties
02/06/2003WO2003010179A1 Process for the preparation of 2'-3'-dideoxy-2',3'-didehydro-nucleosides
02/06/2003WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
02/06/2003WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
02/06/2003WO2002099406A3 Single molecule detection systems and methods
02/06/2003US20030028013 Novel nucleosides having bicyclic sugar moiety
02/06/2003US20030027818 Treatment of cancers
02/06/2003US20030027785 Administering to a subject a purinergic receptor agonist in an amount therapeutically effective to alter the amount or formulation of synovial fluids
02/05/2003EP1281715A1 Process for the preparation of ribavirin
02/05/2003EP1280813A1 Anti-viral pyrimidine nucleoside analogues
02/05/2003EP1280536A2 Method for treating retinal degeneration with purinergic receptor agonists
02/05/2003EP0794787B1 Compositions for the treatment of parasitic and fungal infections
02/04/2003US6514700 Electrophoresis; Used in identification of single nucleotide polymorphisms (snp's)
02/04/2003CA2159038C Protecting group for use in oligodeoxyribonucleotide synthesis
01/2003
01/30/2003WO2003008432A1 Process for the preparation of alpha modified nucleoside triphosphates and compounds therefrom
01/30/2003WO2003007945A1 Viral polymerase inhibitors
01/30/2003US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family
01/30/2003US20030023078 Reacting the anionic form of a 2-chloro-6-substituted purine with a protected and activated 2-deoxy-2-fluoro-D-arabinofuranose; reacting with alkoxide to produce 2-chloro-6-alkoxy purine nucleoside; reacting with ammonia
01/30/2003US20030022862 Protecting/blocking the exocyclic amino function of purine nucleosides without effecting hydroxyl groups of sugar moieties via forming activated ester
01/30/2003US20030022266 Novel agents for replacement of NAD+/NADH system in enzymatic reactions
01/29/2003EP1278760A1 Tag library compounds, compositions, kits and methods of use
01/29/2003EP1278545A1 Combination therapy of respiratory diseases using antibodies
01/29/2003EP1278528A1 Nucleoside analogs with carboxamidine-modified bicyclic base
01/29/2003EP1047704B1 Method for producing fludarabin phosphate lithium, sodium, potassium, calcium and magnesium salts, purification method for producing fludarabin phosphate and fludarabin phosphate which is at least 99.5 % pure
01/29/2003CN1394234A System, method and apparatus for transgenic and targeted mutagenesis screening
01/28/2003US6512107 Generating preferential uridine derivative
01/28/2003US6512106 Nucleoside modifications by palladium catalyzed methods
01/28/2003CA2083534C Indolopyrrolocarbazole derivatives
01/23/2003WO2003006625A2 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
01/23/2003WO2003006475A2 Method for preparation of lna phosphoramidites
01/23/2003WO2003006460A1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
01/23/2003WO2002072595A3 Method for the production of pentopyranosyl nucleosides
01/23/2003US20030018186 Monocyclic L-nucleosides, analogs and uses thereof
01/23/2003US20030018015 Viricides
01/23/2003US20030017551 Biological sample processing methods and compositions that include surfactants
01/23/2003US20030017484 Arrays for detecting nucleic acids
01/23/2003US20030017196 Oligonucleotide inhibitors of bcl-xL
01/23/2003US20030017166 Combination preparation for the therapy of immunological diseases
01/22/2003EP1277759A1 Cytokine related treatments of disease
01/22/2003EP1276901A2 A universal nucleic acid amplification system for nucleic acids in a sample
01/22/2003EP1276749A1 Novel, photo-labile cumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof
01/22/2003EP1276748A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
01/22/2003EP1070078B1 Form vi 5,6-dichloro-2-(isopropylamino)-1-beta-l-ribofuranosyl)-1h-benzimidazole
01/22/2003EP1005478B1 Ribonucleoside-derivative and method for preparing the same
01/22/2003EP0831777B1 Dinucleotides useful for the treatment of lung disease
01/21/2003US6509460 Nucleoside triphosphates and their incorporation into oligonucleotides
01/21/2003US6509459 Base protecting groups and rapid process for oligonucleotide synthesis
01/21/2003US6509320 Purine L-nucleosides, analogs and uses thereof
01/16/2003WO2003004603A2 Methods of modulating pharmacokinetics of oligonucleotides
01/16/2003WO2003004511A2 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
01/16/2003WO2002030944A3 Fluorescent nucleobase conjugates having anionic linkers
01/16/2003WO2001060315A3 Method for the treatment or prevention of flavivirus infections using nucleoside analogues
01/16/2003WO1995032984A8 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs
01/16/2003US20030013869 Esters of cyclic ADP ribose derivatives
01/16/2003US20030013868 C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support
01/16/2003US20030013675 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
01/16/2003US20030013100 Nucleic acid reading and analysis system
01/16/2003CA2452310A1 Methods of modulating pharmacokinetics of oligonucleotides
01/16/2003CA2451738A1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine
01/15/2003EP1275638A1 Combination therapy for the treatment of immunological disorders
01/15/2003EP1274713A1 Anti-viral pyrimidine nucleoside analogues
01/15/2003EP1274704A1 Process for preparing 5'-acetylstavudine
01/15/2003EP1171635A4 Electronically mediated nucleic acid amplification in nasba
01/15/2003EP1015627A4 Method for detecting a target compound using a nucleic acid ligand
01/15/2003CN1391487A Methods for treating therapy-resistant tumors
01/15/2003CN1391486A Methods for treating therapy-resistant tumors
01/15/2003CN1390837A Anti-inflammatory and antineoplastic R-bis or glycophenylpropane isoselenazole substituted compound
01/14/2003US6506896 Conjugated to peptides, proteins, nucleic acids, antibodies, RNA, or DNA; medical diagnosis, electronics
01/14/2003US6506894 Solution phase synthesis of oligonucleotides
01/14/2003US6506888 Viricides, antitumor and anticarcinogenic agents
01/14/2003US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide
01/14/2003CA2294928C Production of avermectin compounds
01/14/2003CA2141494C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
01/09/2003WO2003002588A1 Chemical synthesis of s-adenosyl-l-methionine with enrichment of (s,s)-isomer
01/09/2003WO2003002587A2 Phosphoramide containing nucleic acid-based compounds and libraries as antivirals